Last reviewed · How we verify
NCT05668156: FT
Finding Consensus in Fasting Terminology
trial testing Consensus Decision Making in Consensus Development in 38 participants. Completed in 1 August 2023.
1 August 2023
Quick facts
| Lead sponsor | Charite University, Berlin, Germany |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 38 |
| Start date | 1 February 2022 |
| Primary completion | 1 August 2023 |
| Estimated completion | 1 August 2023 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Consensus Decision Making
Conditions studied
- Consensus Development — all drugs for Consensus Development →
Sponsor
Charite University, Berlin, Germany
Who can join
Eligibility, any sex, with Consensus Development. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A consensus-based decision making process on fasting terminology will be conducted using the Delphi technique. To this aim, experts around the world are invited.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
International consensus on fasting terminology.
Koppold DA, Breinlinger C, Hanslian E, Kessler C, et al · · 2024 · cited 64× · PMID 39059384 · DOI 10.1016/j.cmet.2024.06.013 -
Fasting in Science and Clinics: A Report on Proceedings from the International Scientific Symposium and Conference on Fasting in Berlin (June 2023).
Breinlinger C, Meiß S, Hanslian E, Jordan S, et al · · 2024 · cited 1× · PMID 39128456 · DOI 10.1159/000540668
Verify or expand the search:
- PubMed search for NCT05668156
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Consensus Development
Currently open trials in the same condition.
- NCT06370338 — Cardiothoracic Critical Care as Subspecialty and Its Core Competencies · recruiting
Other Charite University, Berlin, Germany trials
Trials by the same sponsor.
- NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
- NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
- NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
- NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
- NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05668156 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
- Last refreshed: 29 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05668156.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing